Adjuvant treatment using bleomycin in squamous cell carcinoma of penis: study of 19 cases

Br J Urol. 1983 Oct;55(5):542-4. doi: 10.1111/j.1464-410x.1983.tb03366.x.

Abstract

Nineteen patients with squamous cell carcinoma of the penis had surgical treatment or a combination of surgery and radiation. They also had chemotherapy using bleomycin as a single agent or in combination with vincristine and methotrexate. The total doses of bleomycin varied between 89 mg/m2 and 212 mg/m2. The best results were obtained in well differentiated carcinomas.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Bleomycin / therapeutic use*
  • Carcinoma, Squamous Cell / radiotherapy
  • Carcinoma, Squamous Cell / surgery
  • Carcinoma, Squamous Cell / therapy*
  • Combined Modality Therapy
  • Humans
  • Male
  • Methotrexate / administration & dosage
  • Middle Aged
  • Neoplasm Metastasis
  • Penile Neoplasms / radiotherapy
  • Penile Neoplasms / surgery
  • Penile Neoplasms / therapy*
  • Vincristine / administration & dosage

Substances

  • Bleomycin
  • Vincristine
  • Methotrexate